Isodiol International (Isodiol International) ROCE % : -55.55% (As of Dec. 2019)

View and export this data going back to 2014. Start your Free Trial

What is Isodiol International ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Isodiol International's annualized ROCE % for the quarter that ended in Dec. 2019 was -55.55%.

Isodiol International ROCE % Historical Data

The historical data trend for Isodiol International's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Isodiol International ROCE % Chart

Isodiol International Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

ROCE %

Get a 7-Day Free Trial

-730.63

-144.03

-373.72

Isodiol International Quarterly Data
	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19
ROCE %	Get a 7-Day Free Trial															-75.14	-564.24	-102.49	-162.93	-55.55

Isodiol International ROCE % Calculation

Isodiol International's annualized ROCE % for the fiscal year that ended in Mar. 2019 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2019 )		(A: Mar. 2018 )		(A: Mar. 2019 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2019 )		(A: Mar. 2018 )		(A: Mar. 2019 )
	=	-85.964	/	( ( (42.116 - 5.179)	+	(17.664 - 8.597) )	/ 2 )
	=	-85.964	/	( (36.937	+	9.067)	/ 2 )
	=	-85.964	/	23.002
	=	-373.72 %

Isodiol International's ROCE % of for the quarter that ended in Dec. 2019 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2019 )		(Q: Sep. 2019 )		(Q: Dec. 2019 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2019 )		(Q: Sep. 2019 )		(Q: Dec. 2019 )
	=	-2.412	/	( ( (11.076 - 6.387)	+	(8.374 - 4.379) )	/ 2 )
	=	-2.412	/	( ( 4.689	+	3.995 )	/ 2 )
	=	-2.412	/	4.342
	=	-55.55 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2019) EBIT data.

Isodiol International (OTCPK:ISOLF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Isodiol International ROCE % Related Terms

Thank you for viewing the detailed overview of Isodiol International's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Isodiol International (Isodiol International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Isodiol International Inc (OTCPK:ISOLF) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

200 Granville Street, Suite 2710, Vancouver, BC, CAN, V6C 1S4

Website

https://www.isodiol.com

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.